Podchaser Logo
Home
The Lancet Infectious Diseases in conversation with

The Lancet Group

The Lancet Infectious Diseases in conversation with

A monthly Health, Fitness and Medicine podcast
Good podcast? Give it some love!
The Lancet Infectious Diseases in conversation with

The Lancet Group

The Lancet Infectious Diseases in conversation with

Episodes
The Lancet Infectious Diseases in conversation with

The Lancet Group

The Lancet Infectious Diseases in conversation with

A monthly Health, Fitness and Medicine podcast
Good podcast? Give it some love!
Rate Podcast

Episodes of The Lancet Infectious Diseases in conversation with

Mark All
Search Episodes...
Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug develo
Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphi
Sofia Viegas and Stefan Niemann discuss a new article in The Lancet Infectious Diseases about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis.Read the full art
Luciano Moreira and Henrik Salje discuss a new article in The Lancet Infectious Diseases describing the use of the Wolbachia bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil.Read the full article
Richard Maude discusses a new article in The Lancet Infectious Diseases that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia.Read the full article:Antimalarial chemoprophylaxis for forest goers in southeast Asia
Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong.Read the full article:Vaccine effectiveness of one, two, and three doses of BNT162b2 and C
Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021.Read the full article:Clinical features and
Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and EBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in
A new article highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa.Read the full article:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00453-9/fulltextContinue thi
Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated Necator americanus hookworm larvae. Read the full article:https://www.thelancet.com/journals/laninf/a
Josep Llibre discusses a trial on the impact of same-day testing for SARS-CoV-2 infection before a concert on new COVID-19 cases in Barcelona, Spain.Read the full article:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00268-
Yap Boum (MSF) discusses his study done in Cameroon, which developed a promising testing strategy for COVID-19 to optimise the available resources.Read the full article:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00132-8/
Two studies in The Lancet Infectious Diseases describe how the spread of resistance to both dihydroartemisinin and piperaquine is compromising malaria therapy in South-East AsiaContinue this conversation on social!Follow us today at...https://t
A trial investigates the use of a cocktail of phages for the therapy of infections in patients with burns.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://faceboo
Editor of The Lancet Infectious Diseases, John McConnell, discusses the 1918 influenza pandemic and the lessons that can be learnt from it with John Oxford and Jeffery Taubenberger.Continue this conversation on social!Follow us today at...https
Amir Shroufi discusses the early results assessing the safety and efficacy of the combination of bedaquiline and delamanid against drug-resistant tuberculosis.Continue this conversation on social!Follow us today at...https://twitter.com/thelanc
John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS.Continue this conversation on social!Follow us today at...h
Valentina Cambiano discusses the cost-effectiveness of pre-exposure prophylaxis medication in the UK.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com
Christina Wayman talks to Gillian SteelFisher about polio vaccination in Afghanistan.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedica
Kit Fairley discusses The Lancet Infectious Diseases' new Commission on sexually transmitted infections.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.
In our latest Chinese-language podcast, Linjuan Li discusses the epidemiology and evolution of infectious diseases in China in the decade since SARS with Lancet editor Helena Wang.Continue this conversation on social!Follow us today at...https:
In this special Chinese language podcast, Helena Wang is joined by two authors of papers on MCR-1 to discuss their research.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgr
Katherine Gibney discusses her paper on geographic variations and sociodemographic inequities in infectious disease notifications in Australia.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instag
Rob Aldridge discusses the prevalence of and risk factors for tuberculosis in UK migrant.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetme
Ana de Filippis discusses research on how Zika virus has been detected in the amniotic fluid of two pregnant women in Brazil.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetg
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features